People are getting used to the ideal of using metronomic chemotherapy and drug repositioning to treat refractory disease.
Dr. Nicolas Andre, Pediatric Oncologist, Hospital Pour Enfants De La Timone Marseille, France, talks to ETHealthworld about the latest finding from researches and clinical trials in metronomic chemotherapy.
Edited excerpts:
What is Metronomics Global Health Initiative?
Metronomics Global Health Initiative is something that we launched four years ago. We are (…)